Christoph Rosenbohm

Christoph Rosenbohm is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as Entrepreneur in Residence at BiOrigin and as a Technology & Science Advisory Board Member at Corden Pharma. Christoph founded CMC consult by Rosenbohm, which provides services in CMC for oligonucleotides and conjugates to biotech companies and investors. Previously, Christoph held the position of Chief Technology Officer at Aloop Therapeutics and Ceptur Therapeutics, and was the Head of Oligonucleotide Technical Development at Roche. Christoph's extensive experience includes leadership roles at Roche Innovation Center Copenhagen and Santaris Pharma, as well as earlier positions at Cureon and DTU. Academic qualifications include an MBA from Copenhagen Business School, a Post Doc in Carbohydrate Chemistry from DTU, a Ph.D. in Chemistry from the University of Southern Denmark, and a Ph.D. in Organic Chemistry from Scripps Research.